MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, LAB has $567,754K in assets. $143,463K in debts. $120,863K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
419.42%
Quick Ratio
400.97%
Cash Ratio
111.59%
Debt to Asset Ratio
25.27%
Unit: Thousand (K) dollars
Assets Breakdown
    • Current assets held for sale
    • Cash and cash equivalents
    • Short-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Treasury stock at cost 18,580 sh...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
120,863
Short-term investments
66,712
Accounts receivable, net
13,431
Inventory
19,981
Prepaid expenses and other current assets
4,871
Current assets held for sale
228,406
Total current assets
454,264
Property and equipment, gross
66,537
Less accumulated depreciation and amortization
48,162
Construction-in-progress
900
Property and equipment, net
19,275
Operating lease right-of-use asset, net
26,732
Other non-current assets
3,154
Long-term investments
25,701
Deferred tax asset, non-current
38,628
Non-current assets held for sale
0
Total assets
567,754
Accounts payable
5,407
Accrued liabilities
29,783
Operating lease liabilities, current
5,490
Deferred revenue, current
38,949
Deferred grant income, current
3,046
Current liabilities held for sale
25,633
Total current liabilities
108,308
Convertible notes, non-current
299
Deferred tax liability
810
Operating lease liabilities, non-current
25,038
Deferred revenue, non-current
3,503
Deferred grant income, non-current
4,290
Other non-current liabilities
1,215
Total liabilities
143,463
Common stock 0.001 par value, 600,000 shares authorized at december 31, 2025 and 2024 404,961 and 396,110 shares issued at december 31, 2025 and 2024, respectively 386,381 and 377,530 shares outstanding at december 31, 2025 and 2024, respectively
404
Additional paid-in capital
1,732,393
Accumulated other comprehensive income (loss)
-1,492
Accumulated deficit
-1,260,547
Treasury stock at cost 18,580 shares at december 31, 2025 and 2024
46,467
Total stockholders' equity
424,291
Total liabilities and stockholders' equity
567,754
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Current assets held forsale$228,406K Cash and cashequivalents$120,863K Short-term investments$66,712K Inventory$19,981K Accounts receivable, net$13,431K Prepaid expenses andother current assets$4,871K Property and equipment,gross$66,537K Construction-in-progress$900K Total current assets$454,264K Deferred tax asset,non-current$38,628K Operating leaseright-of-use asset, net$26,732K Long-term investments$25,701K Property and equipment,net$19,275K Other non-currentassets$3,154K Less accumulateddepreciation and...$48,162K Total assets$567,754K Total liabilities andstockholders' equity$567,754K Total stockholders'equity$424,291K Total liabilities$143,463K Accumulated deficit-$1,260,547K Treasury stock at cost18,580 shares at...$46,467K Accumulated othercomprehensive income (loss)-$1,492K Additional paid-in capital$1,732,393K Total currentliabilities$108,308K Operating leaseliabilities, non-current$25,038K Deferred grant income,non-current$4,290K Deferred revenue,non-current$3,503K Other non-currentliabilities$1,215K Deferred tax liability$810K Convertible notes,non-current$299K Common stock 0.001 parvalue, 600,000 shares...$404K Deferred revenue,current$38,949K Accrued liabilities$29,783K Current liabilitiesheld for sale$25,633K Operating leaseliabilities, current$5,490K Accounts payable$5,407K Deferred grant income,current$3,046K

STANDARD BIOTOOLS INC. (LAB)

STANDARD BIOTOOLS INC. (LAB)